Page last updated: 2024-08-24

tenofovir and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

tenofovir has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonopoulou, S; Chini, M; Demopoulos, CA; Fragopoulou, E; Gargalianos, P; Lazanas, MC; Mangafas, N; Papakonstantinou, VD; Psarra, K; Stamatakis, GM; Tsogas, N; Tsoupras, AB	1

Other Studies

1 other study(ies) available for tenofovir and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients. Lipids in health and disease, 2014, May-29, Volume: 13 Topics: Adenine; Adult; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Interleukin-10; Interleukin-6; Interleukin-8; Lamivudine; Male; Middle Aged; Organophosphonates; Platelet Activating Factor; Tenofovir; Tumor Necrosis Factor-alpha	2014

Article

Year

In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.

Lipids in health and disease, 2014, May-29, Volume: 13

Topics: Adenine; Adult; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Interleukin-10; Interleukin-6; Interleukin-8; Lamivudine; Male; Middle Aged; Organophosphonates; Platelet Activating Factor; Tenofovir; Tumor Necrosis Factor-alpha

2014